MedCom GmbH | BiopSee will be participating at the 42nd Annual EAU Congress (EAU27) will take place from 19–22 March 2027 at RAI Amsterdam in the Netherlands

at Booth T11

MedCom offers BiopSee: An easy‑to‑use, high‑precision stereotactic, navigated prostate biopsy system for mpMRI–ultrasound fusion. It supports transperineal (stepper or freehand) and transrectal (TRUS) procedures and integrates with a wide range of urological ultrasound systems. Published clinical studies have demonstrated high targeting accuracies of 86–100% for mpMRI‑suspicious lesions and reproducibility in the range of approximately 1 mm when using BiopSee.